A5016525604- Glioma Diagnosis and Treatment
- Immune cells in cancer
- Hormonal Regulation and Hypertension
- Pharmacological Effects and Toxicity Studies
- RNA modifications and cancer
- Epilepsy research and treatment
- Ferroptosis and cancer prognosis
- Inflammatory Biomarkers in Disease Prognosis
Affiliated Hospital of Jining Medical University
2022-2024
Introduction: The independent diagnostic value of inflammatory markers neutrophil to lymphocyte ratio (NLR) and platelet (PLR) the efficacy NLR, derived (dNLR), PLR, lymphocyte-to-monocyte (LMR) in glioma cases remain unclear. We investigated correlation preoperative peripheral blood with pathological grade, Ki-67 Proliferation Index, IDH-1 gene phenotype patients glioma, focusing on tumor grade prognosis. Methods: retrospectively analyzed clinical, pathological, laboratory data 334 varying...
Glioma patients with brain tumor-related epilepsy (BTRE) have a complex profile due to the simultaneous presence of two pathologies, glioma and epilepsy; however, they not traditionally received as much attention those more malignant tumors. The underlying pathophysiology remains poorly understood. purpose this study was investigate possible correlation between molecular neuropathology BTRE wide range BTRE-associated markers patients. A retrospective cohort 186 evaluated at our hospital,...
Objective. Research over the past decade has suggested important roles for pseudogenes in gliomas. Our previous study found that RPL4P4 pseudogene is highly expressed However, its biological function gliomas remains unclear. Methods. In this study, we analyzed clinical data on patients with glioma obtained from The Cancer Genome Atlas (TCGA), Chinese Glioma (CGGA), Genotype-Tissue Expression (GTEx), and GEPIA2 databases. We used R language main analysis. Correlations among expression,...